Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has the potential to align its scope 1 and 2 emissions targets with a 1.5-degree trajectory. Additionally, there is an opportunity for the company to disclose a time-bound target to reduce its scope 3 greenhouse gas emissions. Furthermore, the company has the chance to report progress on these scope 3 targets. Lastly, the company’s scope 3 emissions targets have the potential to be aligned with a 1.5-degree trajectory.
Animal welfare
The company has an opportunity to set animal welfare targets applicable to all species, geographies and products.
Antibiotic use and growth promoting substances
The company has an opportunity to disclose a policy on reducing the (prophylactic) use of antibiotics and/or growth promoting substances. It could also disclose targets to phase out the prophylactic use of antibiotics across all species, geographies and products and report progress against them.
Ecosystem conversion
The company has an opportunity to disclose its efforts to avoid ecosystem conversion, including deforestation or restoration. The company could develop a strategy and publicly report on specific, time-bound targets.
Food loss and waste
The company has an opportunity to disclose its food loss and waste (FLW) reduction targets and report progress against these targets. Additionally, the company can consider aligning its FLW reduction goal with SDG12.3, which aims for a 50% reduction by 2030.
Protein diversification
The company has an opportunity to set a sales-based target to increase alternative proteins across its portfolio, as well as report progress against this target.
Water withdrawal
The company has an opportunity to enhance its disclosures relating to water use and withdrawal.